By Editor , 21 September 2026
IGT and Everi Unveil Integrated Gaming Portfolio at G2E 2026

Las Vegas – September 21, 2026 -- IGT and Everi will present a combined portfolio of slot games, casino management systems and FinTech products at the 2026 Global Gaming Expo (G2E) in Las Vegas, running Sept. 28 through Oct. 1, at booth 4455.

By Editor , 21 September 2026
Ernest Health Secures Sites for 6 NC Rehab Hospitals

Mesquite, Texas – September 21, 2026 -- Ernest Health has secured development sites in six North Carolina markets for freestanding inpatient rehabilitation hospitals, marking Phase 1 of a statewide expansion program. The company controls parcels in Winston-Salem, Mooresville, Gastonia, Hickory, South Asheville/Arden and Goldsboro through development partner Summit Healthcare Group.

By Editor , 21 September 2026
Scinai Regains Nasdaq Compliance on $1.00 Minimum Bid Price Rule

Jerusalem – September 21, 2026 -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) has regained compliance with Nasdaq's $1.00 minimum bid price rule after its American Depositary Shares closed at or above that threshold for 19 consecutive business days, Nasdaq Listing Qualifications confirmed in a September 18, 2026 letter.

By Editor , 21 September 2026
FDA Grants Priority Review to Insmed's ARIKAYCE Full Approval Bid

Bridgewater, N.J. – September 21, 2026 -- The U.S. Food and Drug Administration has accepted Insmed Incorporated's supplemental New Drug Application (sNDA) for full approval of ARIKAYCE (amikacin liposome inhalation suspension) to treat Mycobacterium avium complex (MAC) lung disease, granting Priority Review with a PDUFA target action date of January 28, 2027.

By Editor , 21 September 2026
FDA Grants Platform Designation to Precigen's AdenoVerse Tech

Germantown, Md. – September 21, 2026 -- The U.S. Food and Drug Administration has granted platform technology designation to Precigen's AdenoVerse immunotherapeutic platform, the technology underlying the company's first commercial product, PAPZIMEOS, approved in August 2025 for recurrent respiratory papillomatosis (RRP) in adults.

By Editor , 21 September 2026
Fluxnium Raises $7M to Extract Uranium From Seawater

Los Angeles – September 21, 2026 -- Fluxnium, Inc. has closed a $7 million seed round led by Congruent Ventures to commercialize technology that adsorbs uranium directly from seawater, targeting a domestic alternative to mined ore for nuclear fuel supply. Constellation Technology Ventures, the venture arm of Constellation (NASDAQ: CEG), and Active Impact Investments, Canada's largest climate tech seed fund, also participated in the round.

By Editor , 21 September 2026
enCore Energy Hires North Star for IR, Sets Verdera Share Spinoff

Dallas – September 21, 2026 -- enCore Energy Corp. (NASDAQ, TSXV: EU) has engaged North Star Investor Relations Inc. under a consulting agreement effective September 18, 2026, paying a monthly cash retainer of CAD $10,000 for shareholder outreach, capital markets intelligence and media coordination.

By Editor , 21 September 2026
Vylor, Rainbow Crops Partner on AI-Driven Corn Gene Editing

Johnston, Iowa and Ghent, Belgium – September 21, 2026 -- Vylor, the seed and genetics company set to spin off from Corteva on October 1, 2026, has partnered with Belgium's Rainbow Crops to develop climate-resilient corn traits using AI-driven multiplex gene editing.

By Editor , 21 September 2026
FutureSports, MLB Ink Deal for CME Baseball Futures Indexes

Chicago – September 21, 2026 -- FutureSports has signed an exclusive agreement with Major League Baseball to build rules-based performance indexes on all 30 MLB clubs, clearing the path for CME Group to list cash-settled futures contracts tied to the sport for the first time.

By Editor , 21 September 2026
McDermott Completes $1.05 Billion Refinancing, Rights Offer 97% Subscribed

Houston – September 21, 2026 -- McDermott International, Ltd has completed a comprehensive refinancing package worth more than $1 billion, combining a $500 million equity rights offering, a $550 million senior secured Nordic bond and a new long-term letter of credit facility.